This page contains brief information about loncastuximab tesirine-lpyl and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Loncastuximab tesirine-lpyl is approved to treat:
- B-cell non-Hodgkin lymphoma (NHL), including the following types:
- Diffuse large B-cell lymphoma (DLBCL).
- DLBCL in patients who had low-grade lymphoma.
- High-grade B-cell lymphoma.
Loncastuximab tesirine-lpyl is also being studied in the treatment of other types of cancer.
More About Loncastuximab Tesirine-lpyl
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Loncastuximab Tesirine-lpyl - Check for trials from NCI's list of cancer clinical trials now accepting patients.